ARTICLE | Distillery Therapeutics
Hepatic
October 11, 2018 7:20 PM UTC
Patient sample and mouse studies suggest liver-specific ROCK1 inhibition could help treat non-alcoholic fatty liver disease (NAFLD). In 10 NAFLD patients, liver levels of ROCK1 were higher than in nin...